The separation behavior of a variety of emerging contaminants, including nine antibiotics and six estrogens commonly reported in natural environment, by four commercial nanofiltration and reverse osmosis (NF/RO) membranes at various water conditions (pH, concentration) was investigated. The contaminant rejection at pH 6.0 followed a decreasing trend of XLE (94%-100%) ≈ NF90 (88%-100%) > NF270 (25%-85%) > DL (16%-75%). The dense structures of NF90 and XLE reflected by their small effective pore radii (0.30-0.31 nm) contributed mainly to their high rejection, demonstrating the important role of size exclusion. For the negatively charged loose NF270 and DL membranes (0.40-0.45 nm), charge repulsion made additional contribution, which is markedly reflected by their greater rejection to charged antibiotics than neutral estrogens (45%-85% vs. 25%-60% by NF270). The correlation between rejection data and normalized molecular sizes at pH 4.0 and 9.0 intuitively demonstrated the individual role of size exclusion and charge repulsion. The adsorption by membranes was mainly responsible for the initial compound reduction in feedwater by 6%-25% within 3 h, while only 0.3%-5.6% was attributed to self-degradation. The adsorption capacity was determined, which might be mainly governed by hydrophobic interaction. The resolved controlling factors and mechanisms will contribute to the accurate prediction and membrane selection for trace contaminant removal by membrane process.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jhazmat.2023.132628 | DOI Listing |
Phytother Res
December 2024
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Urinary tract infections (UTIs) are exceptionally common in postmenopausal female or patients with diabetes mellitus or nephrolithiasis, carrying substantial burden on patients and healthcare system. Increasing proportion and ongoing spread of antibiotic-resistant pathogens have further debilitated the condition in battlefield against the UTIs. Lack of estrogen may contribute to high inclination of UTIs after menopause and hormone replacement therapy can mitigate symptoms of hot flashes, vaginal dryness and UTIs, rationalizing the usage of estrogen and analogues in treatment and prophylaxis of UTIs.
View Article and Find Full Text PDFExpert Opin Drug Saf
January 2025
Unit of Obstetrics and Gynecology, Genoa, Italy.
Introduction: Endometriosis and pelvic inflammatory disease (PID) are gynecological conditions affecting women of reproductive age and causing pain symptoms. The symptoms caused by these conditions are similar; thus, the differential diagnosis may be challenging. The treatment of these conditions is very different because PID is treated with antibiotic therapy, while endometriosis is treated with hormonal therapies suppressing estrogen levels.
View Article and Find Full Text PDFUrogynecology (Phila)
December 2024
Department of Obstetrics and Gynecology, Hackensack Meridian Jersey Shore Medical Center, Neptune, NJ.
Importance: Enterococcus faecalis urinary tract infection (UTI) is common in postmenopausal females and these bacteria create biofilms that may reduce treatment efficacy. The role of local vaginal estrogen therapy in susceptibility to E. faecalis infection is unclear.
View Article and Find Full Text PDFJ Ethnopharmacol
December 2024
Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address:
Cancer Drug Resist
November 2024
N.N. Blokhin National Medical Research Center of Oncology, the Ministry of Health of Russia, Moscow 115522, Russia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!